FDA Panel Rejects MDMA for PTSD Amid Safety and Methodology Concerns In The Trials
An FDA advisory panel has recommended against approving MDMA for PTSD treatment, citing significant concerns about the safety and methodological
Read more
Biotech
Cytophage Adds 30-Year Biotech Exec To Its Board
Cytophage Technologies (TSXV: CYTO) has added bench strength to its board of directors this morning, adding a thirty year pharmaceutical and biotech executive to its board.
Read more
PharmaDrug Enters Letter Of Intent With Licensed Dealer For Pharma Grade Cocaine
PharmaDrug Inc (CSE: PHRX) is one step closer to commercializing its biosynthetic, pharmaceutical-grade cocaine. The company as of last week has seen its subsidiary, Securedose Synthetics, sign a letter of intent with a Canadian controlled drug substance licensed dealer.
Read more
PharmaDrug Anticipates Biosynthetic Cocaine Commercial-Scale Production In As Little As 12 Months
PharmaDrug Inc (CSE: PHRX) has established a strategic plan to push forward with its intent to support safe supply programs through the use of its patent pending novel manufacturing method for the commercial-scale production of biosynthetic cocaine.
Read more
Cytophage To Focus On Commercialization Efforts In 2024
Cytophage Technologies (TSXV: CYTO) has filed its fiscal 2023 results, providing a recap on a successful year in terms of corporate development while providing an outline of where the company is headed in 2024.
Read more
DiagnaMed Sees Brain Age AI Platform Validated In Peer-Reviewed Paper
DiagnaMed Holdings (CSE: DMED) is reporting this morning that its flagship Brain Age Brain Health AI Platform has obtained the status of being clinically validated, following the publishing of a peer-reviewed paper.
Read more
DiagnaMed Launches Brain Age Brain Health AI Tool In Canada
DiagnaMed Holdings (CSE: DMED) has officially launched its Brain Age Brain Health AI solution in Canada. Clinics across the country are now able to apply to add the solution to their offerings for supporting brain health.
Read more
PharmaDrug Engages Research Lab To Advance Patented Cocaine Synthesis Method
PharmaDrug (CSE: PHRX) has formally engaged a research lab to refine and advance the development of its patented cocaine synthesis process.
Read more
PharmaDrug: Biosynthetic Pharma-Grade Cocaine
PharmaDrug Inc (CSE: PHRX) last month revealed that it has begun work on developing a novel manufacturing method for a biosynthetic pharmaceutical grade cocaine, which is intended to be used to support safe supply programs being put into place around the globe.
Read more
Cytophage: Landmark Phage Therapy Saves Ottawa Woman From Life-Threatening Infection
A 79-year-old resident from the Ottawa area credits an experimental treatment developed in Winnipeg with saving her life from a chronic artificial joint infection.
Read more